A detailed history of Alkeon Capital Management LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Alkeon Capital Management LLC holds 1,897,601 shares of KROS stock, worth $32.5 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
1,897,601
Previous 1,598,907 18.68%
Holding current value
$32.5 Million
Previous $73.1 Million 50.8%
% of portfolio
0.19%
Previous 0.12%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$41.68 - $58.07 $12.4 Million - $17.3 Million
298,694 Added 18.68%
1,897,601 $110 Million
Q1 2024

May 14, 2024

BUY
$41.26 - $70.48 $4.13 Million - $7.05 Million
100,000 Added 6.67%
1,598,907 $106 Million
Q4 2023

Feb 13, 2024

SELL
$27.12 - $41.05 $4.82 Million - $7.29 Million
-177,615 Reduced 10.59%
1,498,907 $59.6 Million
Q2 2023

Aug 11, 2023

SELL
$37.26 - $51.01 $55,740 - $76,310
-1,496 Reduced 0.09%
1,676,522 $67.4 Million
Q1 2023

May 12, 2023

BUY
$41.44 - $59.32 $11.8 Million - $16.9 Million
285,616 Added 20.51%
1,678,018 $71.7 Million
Q4 2022

Feb 13, 2023

BUY
$39.45 - $51.77 $7.24 Million - $9.5 Million
183,580 Added 15.19%
1,392,402 $66.9 Million
Q3 2022

Nov 10, 2022

BUY
$27.8 - $40.12 $900,414 - $1.3 Million
32,389 Added 2.75%
1,208,822 $45.5 Million
Q2 2022

Aug 15, 2022

BUY
$26.03 - $67.04 $7.03 Million - $18.1 Million
270,000 Added 29.79%
1,176,433 $32.5 Million
Q1 2022

May 16, 2022

SELL
$42.12 - $59.36 $842,400 - $1.19 Million
-20,000 Reduced 2.16%
906,433 $49.3 Million
Q4 2021

Feb 14, 2022

BUY
$36.95 - $62.89 $8.31 Million - $14.2 Million
225,000 Added 32.08%
926,433 $54.2 Million
Q3 2021

Nov 15, 2021

SELL
$29.27 - $43.71 $58,715 - $87,682
-2,006 Reduced 0.29%
701,433 $27.7 Million
Q2 2021

Aug 16, 2021

BUY
$42.4 - $70.11 $7.63 Million - $12.6 Million
180,000 Added 34.39%
703,439 $29.9 Million
Q1 2021

May 17, 2021

BUY
$54.0 - $75.28 $71,172 - $99,219
1,318 Added 0.25%
523,439 $32.2 Million
Q4 2020

Feb 16, 2021

BUY
$36.0 - $82.74 $17.7 Million - $40.7 Million
492,121 Added 1640.4%
522,121 $36.8 Million
Q2 2020

Aug 14, 2020

BUY
$20.08 - $40.39 $602,400 - $1.21 Million
30,000 New
30,000 $1.13 Million

Others Institutions Holding KROS

About Keros Therapeutics, Inc.


  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $441M
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Alkeon Capital Management LLC Portfolio

Follow Alkeon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alkeon Capital Management LLC with notifications on news.